Locations:
SearchMore prescriptive system not a concern if patients benefit
In value-based care, the adoption of care paths – standardized, evidence-based treatment regimens – are an important way of improving efficiency and outcomes. But how do physicians react to what might seem a more prescriptive system?
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Very well, if Cleveland Clinic Cancer Center’s experience is an indication. “Our physicians appreciate a care path for a given diagnosis that is state of the art,” Taussig Cancer Institute Chairman Brian J. Bolwell, MD, FACP, says in this video about value-based cancer care. Acceptance “has been surprisingly easy.”
Click here to view more cancer related videos.
Photo Credit ©Russell Lee
Advertisement
Advertisement
Timing and type of side effects differ greatly from chemotherapy
Dedicated multidisciplinary teams support 84 ultra-rare cancers
Sessions explore treatment advances and multidisciplinary care
New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues
Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations
Early communication between oncologists and ophthalmologist warranted
Case-based course delves into latest treatment approaches
Long-term relationship building and engagement key to gaining community trust